Oncode Scientific

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

Slider
A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

A New Way In Battling Cancer
COMPROMISE NOT ON YOUR QUALITY OF LIFE WHILE YOU BATTLE AGAINST CANCER

In Oncode, we want to help you in making the right choice and the best possible decisions when it comes to cancer treatments. Oncode tailormade precision medicine tests enable you to be rest assured that you are always on the right track.

Slider

How We Help in Your Cancer Treatment?

Identify the Genetic Alterations of your Cancer
Knowing the root genetic alterations that cause the occurrence of your cancer enable us to provide your physician with treatment options tailor-made to battle against your cancer
Your Personalize Report with Beneficial Drugs Suggestion
Oncode report suggests list of treatment options including targeted therapy, immunotherapy, chemotherapy, radiation, hormonal therapy & more, which work optimally for you
Ruling-Out & Avoid Less Beneficial Treatments
Based on your genetic profile, Oncode report gives you information on treatment options which are less effective/ beneficial to you; so that your physician may avoid using them
Aid to Plan for the most Cost-Effective Treatment Approach
By choosing the most suitable treatment option(s), you can avoid trial & error approaches which will simply lessen your financial burden, and minimizing unnecessary side effects
Listing of Available Free Drug Clinical Trials
Oncode report connects patients with matching eligibility to clinical trials held by distinguished pharmaceutical companies. Enrolment provides access to free new drugs
Precision Medicine Tests are Covered by Insurance
Depending on your insurance policy, most insurance companies do cover the cost of genetic profiling. You may contact us to obtain the insurance claim form to be submitted to your insurance company for claim
Identify the Genetic Alterations of your Cancer
Knowing the root genetic alterations that cause the occurrence of your cancer enable us to provide your physician with treatment options tailor-made to battle against your cancer
Your Personalize Report with Beneficial Drugs Suggestion
Oncode report suggests list of treatment options including targeted therapy, immunotherapy, chemotherapy, radiation, hormonal therapy & more, which work optimally for you
Ruling-Out & Avoid Less Beneficial Treatments
Based on your genetic profile, Oncode report gives you information on treatment options which are less effective/ beneficial to you; so that your physician may avoid using them
Aid to Plan for the most Cost-Effective Treatment Approach
By choosing the most suitable treatment option(s), you can avoid trial & error approaches which will simply lessen your financial burden, and minimizing unnecessary side effects
Listing of Available Free Drug Clinical Trials
Oncode report connects patients with matching eligibility to clinical trials held by distinguished pharmaceutical companies. Enrolment provides access to free new drugs
Precision Medicine Tests are Covered by Insurance
Depending on your insurance policy, most insurance companies do cover the cost of genetic profiling. You may contact us to obtain the insurance claim form to be submitted to your insurance company for claim

If you are diagnosed with

Solid Tumours
Blood Cancers

We Offer

Tissue Testing

List of tests done using the tissue biopsy of the patient. Check out our list of tissue tests now!

LIQUID BIOPSY (BLOOD)

Non-invasive tumour profiling test
done by just using the blood of patient.
Check out our liquid biopsy test now!

If you are diagnosed with

Solid Tumours
Blood Cancers

We Offer

Tissue Testing

List of tests done using the tissue biopsy of the patient. Check out our list of tissue tests now!

LIQUID BIOPSY (BLOOD)

Non-invasive tumour profiling test
done by just using the blood of patient.
Check out our liquid biopsy test now!

ACTUAL ONCODE PATIENTS CASE STUDIES

Male, 70, Metastatic Melanoma
Patient was on conventional cancer treatment until lung metastasis was discovered, his physician has opted for immunotherapy as treatment option. However, due to high treatment cost, the patient’s family would like to explore more treatment options with ONCODE. ONCODEcipher report has shown that patient is BRAF V600E positive, which makes patient an eligible candidate for enrolment into clinical trial. New drug combinations have been prescribed to the patient by his physician with zero expenses for the medication. Conclusion: Patient is now doing well with the new drug combination with minimum side effects.

ACTUAL ONCODE PATIENTS CASE STUDIES

Female, 65, Metastatic Breast Cancer
Patient’s condition was worsening despite on chemotherapy, patient had engaged with ONCODE for a comprehensive liquid biopsy genomic profiling, which includes BRCA gene testing. ONCODEcipher report has shown that patient is positive for pathogenic BRCA2 and AKT1, which makes patient a suitable candidate for PARP inhibitors treatment and clinical trial candidate for AKT1 inhibitor. With AKT1 mutation, endocrine therapy is less likely to be beneficial for this patient, thus endocrine therapy was avoided.
Conclusion: Patient is now waiting to receive approval for enrolment into new PARP inhibitor drug trial.

ACTUAL ONCODE PATIENTS CASE STUDIES

Female, 27, Acute Leukemia
Physician has ordered an ONCODEduce test, report shows that the patient manifests FLT3-ITD, KIT and CEBPA mutations. ONCODEduce report has not only summarised treatment options including bone marrow transplant. With allele frequency information (one of important clues to check for hereditary factor), all family members of patient were recommended by physician to check for hereditary gene mutation. This is to rule out the risk factor of disease development in family members, as well as exploring bone marrow transplant as one of the treatment options for this patient. All family members were detected negative for the gene mutations and thus there is no risk factors of developing the same cancer as patient due to the said genes.
Conclusion: This patient has gone for bone marrow transplant, donated by her family member.

HOW TO ORDER A TEST FROM ONCODE

ASSESSMENT

Clinicians will perform clinical examination, and contact Oncode technical support team for the selection of appropriate genetic tests.

ORDERING

Clinician will fill in the Test Requisition Form in Oncode specimen collection kit. Draw blood from patients and/or request hospital labs to prepare FFPE specimens (if required).

ANALYSIS

Oncode laboratory will perform tests, generate and send reports to clinicians within stated turn-around time.

RESULTS

Clinicians will explain report to patients. Clinical support team of Oncode laboratory is available for support and explanation of test results.

WISH TO KNOW MORE ABOUT ONCODE TEST?

  • Precision medicine, or also known as personalized medicine, is an approach that helps the doctors to understand a person’s genetic makeup and select the suitable treatments that may be more effective for the patients.
  • Before precision medicine, when you are diagnosed with cancer, you usually will receive the same treatment as others with the same type and stage of cancer. However, it has been noted that certain treatments worked better for some people while ineffective in others.
  • Researchers have discovered that different responses of patients to the same treatment is due to the genetic differences in them that cause cancer to grow and spread.
  • Cancer profiling is able to help the doctors to understand the genetic mutations that cause your cancer and decide a more effective treatment plan that targets these mutations.
  • The genetic profiling report will not only list the available drugs that are effective against these mutations but also drugs that are not likely to work on you.
  • Cancer profiling can also help to identify the presence of new mutations through continuous monitoring for genetic changes during and after treatment. The occurrence of these new mutations may indicate resistance to the previous treatment, and in these cases, another drug that targets this new mutation can be used for cancer control.
  • Targeted cancer therapies are drugs approved by the FDA that have been proven to be effective against cancer with specific genetic mutations.
  • Targeted therapies generally have fewer side effects as compared to conventional chemotherapy.
  • If there is a targeted drug or treatment approved for your cancer type, you can be tested to see whether the genetic mutation targeted by the drug is present in your cancer.
  • If there is no approved targeted drug or treatment for your cancer type, you may still be tested for genetic mutation to see whether you are eligible for drug clinical trial of targeted therapy.

WOMEN

  • Breast cancer diagnosed at age 50 or younger
  • Ovarian cancer at any age
  • Both breast and ovarian cancer
  • Uterine cancer diagnosed <50 years of age or with abnormal microsatellite instability
  • Multiple primary cancers in one person (e.g. uterine and breast or thyroid cancer)
  • Triple-negative (hormone-receptor negative and HER2/neu negative) breast cancer
  • Pancreatic cancer with breast or ovarian cancer in the same individual or on the same side of the family
  • Multiple close family members with breast or ovarian cancer

MEN

    • Has breast cancer at any age
    • Pancreatic cancer or prostate cancer at any age
    • Two or more family members with breast, ovarian, pancreatic, and/or prostate cancer at any age

Yes, you can still be tested after received chemotherapy treatment. Oncode tests can help to identify the presence of new mutations through continuous monitoring during and after treatment.

Scroll to Top